Skip to main content
Premium Trial:

Request an Annual Quote

Febit to Participate in Setup of Biomarker Discovery Center Heidelberg

NEW YORK (GenomeWeb News) - Febit this month will help establish Biomarker Discovery Center Heidelberg, a project recently awarded funding from the Excellence Cluster Initiative of the German Federal Ministry of Education and Research.

The project is being funded as part of a €40 million ($51.6 million) grant to develop a biotech excellence cluster in the region of Rhine Neckar in Germany for the development of innovative drugs, diagnostics, and technologies in cellular and molecular biology.

As part of its contribution, Febit said today that it will offer both array and second-generation sequencing-based analysis to aid in the development and validation of novel biomarkers. The company will also work with the German Cancer Research Center (DKFZ) on studies to identify markers for various cancer types and to develop these markers into standardized diagnostic assays.